Amia Capital LLP Kezar Life Sciences, Inc. Transaction History

Amia Capital LLP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 11, 2021	SELL	$4.77 - $6.58 $110,444 - $152,353	-23,154 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$4.36 - $5.5 $43,800 - $55,253	10,046 Added 76.64%	23,154 $112,000
Q2 2020 Aug 14, 2020	SELL	$3.6 - $7.75 $1,468 - $3,162	-408 Reduced 3.02%	13,108 $68,000
Q1 2020 May 15, 2020	BUY	$2.77 - $5.75 $37,439 - $77,717	13,516 New	13,516 $59,000

38.4M

13.8K

600

Ticker KZR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,369,504
Market Cap $506M
Description
Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical tria...

Get notified when there are updates to the investment portfolio of Amia Capital LLP, based on Form 13F filings with the SEC.

Stay updated on Amia Capital LLP with notifications on news.